Clinical development of liposomal platinum

Roman Perez Soler; A. R. Khokhar; Julio Lautersztain; Salam Al Baker; Karen Francis; Dede Macias Kiger; G. Lopez Berestein

doi:10.3109/08982109009036006

Clinical development of liposomal platinum

Roman Perez Soler, A. R. Khokhar, Julio Lautersztain, Salam Al Baker, Karen Francis, Dede Macias Kiger, G. Lopez Berestein

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

We have been interested for several years in the development of carrier-dependent antitumor agents. these agents should have the following properties: enhanced antitumor activity compared with the parent compound, decreased toxicity, lack of cross-resistance, and compatibility with the drug carrier.

Original language	English (US)
Pages (from-to)	437-449
Number of pages	13
Journal	Journal of Liposome Research
Volume	1
Issue number	4
DOIs	https://doi.org/10.3109/08982109009036006
State	Published - 1990
Externally published	Yes

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.3109/08982109009036006

Cite this

@article{0f5043d7df224666abb937bac1e056c3,

title = "Clinical development of liposomal platinum",

abstract = "We have been interested for several years in the development of carrier-dependent antitumor agents. these agents should have the following properties: enhanced antitumor activity compared with the parent compound, decreased toxicity, lack of cross-resistance, and compatibility with the drug carrier.",

author = "Soler, {Roman Perez} and Khokhar, {A. R.} and Julio Lautersztain and Baker, {Salam Al} and Karen Francis and Kiger, {Dede Macias} and Berestein, {G. Lopez}",

note = "Funding Information: This work was supported in part by NIH Grants CA 45423 (R.P.-S.), CA 41581 (A.R.K.), and a grant from The Liposome Company (Princeton, NJ).",

year = "1990",

doi = "10.3109/08982109009036006",

language = "English (US)",

volume = "1",

pages = "437--449",

journal = "Journal of Liposome Research",

issn = "0898-2104",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Clinical development of liposomal platinum

AU - Soler, Roman Perez

AU - Khokhar, A. R.

AU - Lautersztain, Julio

AU - Baker, Salam Al

AU - Francis, Karen

AU - Kiger, Dede Macias

AU - Berestein, G. Lopez

N1 - Funding Information: This work was supported in part by NIH Grants CA 45423 (R.P.-S.), CA 41581 (A.R.K.), and a grant from The Liposome Company (Princeton, NJ).

PY - 1990

Y1 - 1990

N2 - We have been interested for several years in the development of carrier-dependent antitumor agents. these agents should have the following properties: enhanced antitumor activity compared with the parent compound, decreased toxicity, lack of cross-resistance, and compatibility with the drug carrier.

AB - We have been interested for several years in the development of carrier-dependent antitumor agents. these agents should have the following properties: enhanced antitumor activity compared with the parent compound, decreased toxicity, lack of cross-resistance, and compatibility with the drug carrier.

UR - http://www.scopus.com/inward/record.url?scp=0025697199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025697199&partnerID=8YFLogxK

U2 - 10.3109/08982109009036006

DO - 10.3109/08982109009036006

M3 - Article

AN - SCOPUS:0025697199

SN - 0898-2104

VL - 1

SP - 437

EP - 449

JO - Journal of Liposome Research

JF - Journal of Liposome Research

IS - 4

ER -

Clinical development of liposomal platinum

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this